| Financial Year |
March 31 2023 |
| Monetary Funds |
2,205,686,129.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,937,889,863.61 |
| Accounts Receivable |
9,899,780,252.53 |
| Advances to Suppliers |
238,918,154.74 |
| Other Receivables |
128,752,493.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
270,277.78 |
| Dividend Receivable |
-- |
| Inventories |
7,393,208,378.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
210,703,468.02 |
| Total Current Assets |
22,021,529,741.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
30,501,738.10 |
| Investment Properties |
163,185,763.74 |
| Fixed Assetes |
4,412,512,178.94 |
| Under-construction Projects |
674,756,818.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
720,221,602.04 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,762,512.09 |
| Deferred Income Tax Assets |
115,194,092.36 |
| Other Non-Current Assets |
129,784,119.60 |
| Sub-Total of Non-Current Assets |
6,530,199,674.08 |
| Total Assets |
28,551,729,415.60 |
| Short-Term Loans |
2,947,491,602.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,142,585,026.31 |
| Accounts Payable |
6,278,774,874.02 |
| Accounts Received In Advance |
22,845,698.25 |
| Employee Compensation Payable |
218,445,944.80 |
| Taxes Payable |
73,096,061.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
153,990,419.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,050,891,830.72 |
| Other Current Liabilities |
146,065,849.32 |
| Sub-Total of Current Liabilities |
13,395,035,370.94 |
| Long-term Loans |
2,063,807,126.24 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-863,091,398.62 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,496,168.70 |
| Other Non-Current Liabilities |
589,931,903.57 |
| Sub-Total of Non-Current Liabilities |
2,291,363,134.50 |
| Total Liabilities |
15,686,398,505.44 |
| Paid-In Capital(Or Share Stock) |
1,917,798,835.00 |
| Capital Surplus |
4,279,746,081.91 |
| Surplus Reserve |
521,714,922.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,646,191,882.86 |
| Minority Stockholder's Interest |
449,103,907.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,416,227,002.57 |
| Owner's Equity（Stockholder's Equity） |
12,865,330,910.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,551,729,415.60 |
